期刊文献+

保妇康栓联合乳酸菌阴道胶囊治疗妊娠期霉菌性阴道炎的临床效果 被引量:23

the Clinical Effect of Baofukang suppository Combined Lactobacillus Vagina Capsule Treatment Mould Sex Vaginitis During Pregnancy
暂未订购
导出
摘要 目的保妇康栓联合乳酸菌阴道胶囊治疗妊娠期霉菌性阴道炎的临床效果。方法将100例经临床确诊的霉菌性阴道炎患者随机分为观察组和对照组各50例,观察组给予保妇康栓联合乳酸菌阴道胶囊治疗,对照组给予保妇康治疗,比较两组患者的治疗效果。结果组治愈率为90%;对照组治愈率为74%,观察组显著高于对照组,两组比较,差异具有统计学意义(P<0.05)。结论保妇康与乳酸菌阴道胶囊联合治疗霉菌性阴道炎疗效确切,值得临床广泛应用。 Objective Baofukang suppository combined lactobacillus vagina capsule treatment, the clinical effect of mould sex vaginitis during pregnancy. Methods Will be 100 cases of clinically diagnosed with mould sex vaginitis were randomly divided into observation group and control group 50 cases each, observation group was given Baofukang suppository combined lactobaeillus vagina capsule treatment, control group given bao fu kang treatment, compare the curative effect of two groups of patients. Results Group the cure rate is 90%; Control group cure rate was 74%, the observation group is significantly higher than the control group, two groups of comparisons, the difference was statistically significant (P〈0.05). Conclusion Baofukang and lactobacillus vagina capsule combined treatment curative effect is mould sex vaginitis, worthy of clinical application widely.
作者 王秀艳
出处 《中国医药指南》 2013年第16期19-20,共2页 Guide of China Medicine
关键词 保妇康栓 乳酸菌阴道胶囊 妊娠 念珠菌性阴道炎 Baofukang suppository Lactobacillus vagina capsule Pregnancy Vaginal yeast infection
  • 相关文献

参考文献3

二级参考文献14

  • 1Sexually Transmitted Disease Treatment Guidelines 2002[J].Centers for Disease Control and Prevention.MMWR,2002,51(RR-6):45-48.
  • 2Sojakova M,Liptajova D,Simoncicova M,et al.Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics[J].Ceska Gynekol,2003,68:24-29.
  • 3Linda O,Eckert S,Hawes C,et al.Vulvovaginal candidiasis:Clinical manifestations,risk factors,management algorithm[J].Obstet Gynecol,1998,92:757-765.
  • 4Edwards L.The diagnosis and treatment of infectious vaginitis[J].Dermatol Ther,2004,17:102-110.
  • 5French L,Horton J,Matousek M.Abnormal vaginal discharge:what does and does not work in treating underlying causes[J].J Fam Pract,2004,53:890-894.
  • 6Geiger AM,Foxman B.Risk factors for vulvovaginal candidiasis:a case-control study among university students[J].Epidemiology,1996,7:182-187.
  • 7Kazerooni T,Mosalaee A.Does contraceptive method change the Pap smear finding[J].Contraception,2002,66:243-246.
  • 8Ferrer J.Vaginal candidosis:epidemiological and etiological factors[J].Int J Gynaecol Obstet,2000,71(Suppl1):S21-27.
  • 9Mendling W,Pinto De Andrade M,Gutschmidt J,et al.Strain specificity of yeasts isolated from different locations of women suffering from vaginal candidosis,and their partners[J].Mycoses,2000,43:387-392.
  • 10Rylander E,Berglund AL,Krassny C,et al.Vulvovaginal candida in a young sexually active population:prevalence and association with oro-genital sex and frequent pain at intercourse[J].Sex Transm Infect,2004,80:54-57.

共引文献31

同被引文献124

引证文献23

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部